BCM
Bayesian Capital Management’s Allogene Therapeutics ALLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,402
| Closed | -$82.5K | – | 655 |
|
|
2024
Q2 | $82.5K | Buy |
+35,402
| New | +$82.5K | 0.01% | 657 |
|
|
2023
Q4 | – | Sell |
-26,500
| Closed | -$84K | – | 725 |
|
|
2023
Q3 | $84K | Buy |
26,500
+12,400
| +88% | +$39.3K | 0.01% | 620 |
|
|
2023
Q2 | $70.1K | Buy |
+14,100
| New | +$70.1K | 0.01% | 712 |
|
|
2022
Q2 | – | Sell |
-30,400
| Closed | -$277K | – | 763 |
|
|
2022
Q1 | $277K | Buy |
+30,400
| New | +$277K | 0.04% | 544 |
|